Many experts and drug industry leaders consider Brazil to be the largest drug market in the world. Not only does Brazil have a large population with more than 200 million people, but the drug consumption rates in this country are quite high. As a result, many drug and pharmaceutical companies have been vying to get approved for the import of their products into Brazil.
Recently, the government of Brazil approved the import of Real Scientific Hemp Oil™ as a medication for chronic pain. RSHO™ is a cannabidiol (CBD) hemp oil product produced by Medical Marijuana, Inc. While chronic pain was the third indication for the import of RSHO™, the first two indications were Parkinson’s disease and epilepsy. Shareholders of Medical Marijuana, Inc. (OTC: MJNA) will be happy to know that many experts report that there is much to look forward to in terms of the market and opportunity for RSHO™ and other CBD hemp oil products in Brazil.
Drug Laws in Brazil
While marijuana for recreational use is still considered illegal in Brazil, many believe that the recreational use of marijuana is on the brink of being decriminalized. In Brazil, there have been many movements pushing for the decriminalization of the use of marijuana. In fact, due to these movements, the Brazilian Supreme Court has considered legalizing marijuana for recreational use on more than one occasion.
While marijuana for recreational use is outlawed, the Brazilian government has permitted the use of CBD hemp oil products as all-natural medications. This shows that Brazil realizes that non-psychoactive hemp oil products possess properties that make it a useful treatment for a variety of ailments, such as pain. It also indicates that Brazil realizes that certain cannabinoids including CBD, in contrast to tetrahydrocannabinol (THC), lack psychotropic and euphoric effects. The non-psychoactive cannabinoid, CBD, also lacks the toxicity that is often associated with other products including prescription medications.
Even though research studies show that there are many advantages of using all-natural cannabinoids, many countries fail to recognize the difference between specific cannabinoids and classify the entire plant species into one category: cannabis. This fact alone makes the drugs laws in Brazil far more advanced and open than the drug laws of many other countries in the world. It also explains why so many companies in the medical marijuana industry are eager to have permission to import their products into Brazil.
Drug Market in Brazil
The huge drug market in Brazil is another reason why experts believe that there is much to look forward to in terms of the market and opportunity. Without a doubt, Brazil is most well-known for its illegal drug market industry. In fact, Brazil is often referred to as “Crackland” due to the crack cocaine epidemic that is currently ravaging the country.
However, it is important to realize that the legal drug market industry in Brazil is also bustling, mainly due to the large population in Brazil. Many pain medications offered in Brazil are ineffective or highly addictive. Therefore, experts believe that many Brazilians will be requesting a prescription for medical cannabis to manage their pain.
Issues with Drug Addiction in Brazil
Without a doubt, drug addiction is a huge issue in Brazil. While the issue is most prevalent when it comes to crack and cocaine, the issue is also significant when it comes to pain medications. Plenty of research shows that pain medications can be very addictive, which explains why the issue of pain medication addiction exists in almost every country in the world. It is possible that all-natural cannabidiol products may be a solution to this issue.
Cannabidiol is not habit forming; many cannabis research studies have supported this assertion. Due to the lack of addictive properties for cannabidiol products, it is possible that the incidence of overdosing on pain medications may reduce significantly with the introduction of cannabidiol products as all-natural pain medications.
Shareholders for Medical Marijuana, Inc. and the Brazilian public alike have much to look forward to when it comes to the introduction of RSHO™ to the medical industry of Brazil. Any Brazilians with an indication recognized by the government who want to use RSHO™ hemp oil products will be able to do so as long as they obtain a doctor’s prescription and proper import documentation from the ANVISA. Medical Marijuana, Inc. strives to be a pioneer in the hemp industry and this major achievement is a huge step forward for the ultimate mission of the company.
Chronic pain includes taxing ailments such as migraine headaches. Migraine is specifically mentioned in Dr. Ethan Russo’s study, Clinical Endocannabinoid Deficiency Syndrome (CEDS). In which, for example, if a person is cannabinoid deficient, that person may likely develop many “difficult-to-treat” conditions, such as fibromyalgia, irritable bowel syndrome, migraine headache.
One way to consider the future impact of cannabinoids is this: Many generations ago Scurvy was almost at epidemic proportions. Now with Vitamin C discovered, most doctors today have never seen a Scurvy patient. Soon, with cannabinoids, there may be no more fibromyalgia, chronic fatigue, irritable bowel, and several other chronic conditions.
This population of patients, who have seen little-to-no hope from traditional medical treatment, may now have hope for their future – and hope for an improved quality of life through cannabinoid-based therapies. While the medical community is researching the effects to be satisfactorily convinced, many patients are not waiting to take advantage of a natural botanical form of CBD – some are reporting benefit through their anecdotal stories of success.
CEO for SmallCapVoice.com, Inc.
For more information on our clients and services please visit http://SmallCapVoice.com